ArticleJournal of gastrointestinal cancer2026
Clinical Characteristics and Outcomes Associated with Clostridium Difficile Infection among Hospitalized Colorectal Cancer Patients Receiving Chemotherapy: a Nationwide Retrospective Analysis.
Article in Journal of gastrointestinal cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundClostridioides difficile infection (CDI) remains a significant cause of morbidity among hospitalized patients, yet contemporary data evaluating its impact in patients with colorectal cancer (CRC) receiving chemotherapy are limited. We aimed to assess the clinical outcomes associated with CDI in this population using a large national database.
methodsWe conducted a retrospective cross-sectional study using the National Inpatient Sample (NIS) from 2016 to 2021. Adult hospitalizations with a diagnosis of CRC and receipt of chemotherapy were identified using ICD-10-CM and procedural codes. CDI was defined using ICD-10-CM codes (A047.x). Survey-weighted analyses were performed to evaluate associations between CDI and in-hospital mortality, length of stay (LOS), and total hospitalization costs. Multivariable logistic and linear regression models adjusted for demographic, socioeconomic, and hospital-level characteristics.
resultsAmong 7,680 weighted hospitalizations, CDI occurred in approximately 1.6% of admissions. Patients with CDI were older (mean age 70.1 vs. 62.5 years; p < 0.01) and had higher in-hospital mortality (aOR 2.55; 95% CI, 1.45–4.48; p = 0.001), longer hospitalization (β 0.85; p < 0.001), and increased costs (β 0.78; p < 0.001). CDI occurred more frequently in patients with sepsis (5.1% vs. 1.2%; p < 0.001) and critical illness with shock (3.2% vs. 1.6%; p = 0.075). Demographic and hospital-level factors showed limited association with CDI after adjustment.
conclusionsIn this nationally representative cohort of hospitalized patients with CRC receiving chemotherapy, CDI was associated with significantly increased in-hospital mortality, length of stay, and healthcare utilization. These findings underscore the substantial clinical and economic burden of CDI in this vulnerable population and highlight the importance of early recognition, prevention, and targeted management strategies.
Indexed as
Identifiers
41874847What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.